Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment [NA]

View source ↗

Summary

A clinical trial from the Weizmann Institute of Science is investigating the role of the gut microbiome in recurrent obesity and how antibiotic treatment versus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Weizmann Institute of Science | Conditions: Obesity, Weight Loss | NA | Status: RECRUITING